April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
John Rossi, Ph.D., receives highest honor from American Society of Gene and Cell Therapy
April 29, 2019 | Michael Easterling
John Rossi, Ph.D., the Lidow Family Research Chair and professor of the Department of Molecular and Cellular Biology, is the recipient of the 2019 Outstanding Achievement Award presented by the American Society of Gene and Cell Therapy.
Researchers Use Nanoparticles to Test Treatment for Liver Disease
June 25, 2018 | Katie Neith
In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.
April 1, 2013 | Nick Snead
I saw this paper published in Science , authored by (as one of my undergraduate biomedical engineering biomaterials professors put it) one of the "demigods" of biomaterials, Bob Langer, and an up-and-coming materials scientist named Dan Anderson, who is making lots of siRNA-delivery biomaterials, too.
How I came to City of Hope: the transition from engineering to biology
March 6, 2012 | Nick Snead
I often joke that, when I was studying biomedical engineering, we were only encouraged to learn the bare minimum of the biology that we needed to know in order to do our project. It was, however, partly true.
Blood stem cells - evolving compensation
March 5, 2012 | Krist Azizian
Disrupting a critical molecular pathway for blood development reveals biology’s robustness. Some faint at the sight of it. Others relish seeing it splattered gratuitously in vampire movies. Blood, with all its symbolism, has intrigued mankind for millennia.